Table 1.
Compound | Description | Pre‐clinical data | Human triala |
---|---|---|---|
Liver‐extracted proteins | Fatty liver‐derived proteins | +77 | − |
Anti‐CD3 | Anti‐CD3 antibodies | +76 | +119 |
PRX106 | Anti TNF fusion protein | +124 | +a, 83 |
Imm124E | Anti‐LPS antibodies | +109 | +123 |
Glycosphingolipids | Glucosylceramide | +90, 91, 92 | +125 |
DR‐MP | Delayed‐release mercaptopurine | − | +a, 72 |
OS M1 | Soy‐derived extracts | +102 | − |
Tested for other indications.